Study Evaluating Long-Term Safety of Effexor XR in Patients With Major Depression.
Phase 3
Completed
- Conditions
- Depression
- Registration Number
- NCT00225524
- Lead Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Brief Summary
Phase III long-term safety study of Effexor XR in patients with major depression.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
- Patients who complete the Phase III double-blind study (Protocol Number 0600B1-816)
Exclusion Criteria
- Patients with schizophrenia or any other psychotic disorder
- Patients with history or presence of bipolar disorder
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Incidence of adverse events
- Secondary Outcome Measures
Name Time Method Quantitative data for laboratory data